Shasqi presented a poster at the 2024 American Society of Oncology (ASCO) Annual Meeting on June 1, 2024 in Chicago, Illinois. The poster was titled, Phase 2a results of SQ3370, a doxorubicin-based click chemistry therapeutic in patients with advanced STS: Planned interim analysis.
